Laboratory Markers | Median value (IQR) | Imaging Features | N (%) | |
---|---|---|---|---|
Blood cell counts |  | Chest X-ray (n = 4) |  |  |
Total white cell counts (×10/L) (n = 8) | 9.79 (8.06–13.19) | Pulmonary consolidation |  | 2 (50.0) |
Neutrophils (×109/L) (n = 7) | 5.26 (3.94–8.36) | Pleural effusion |  | 2 (50.0) |
Lymphocytes (×109/L) (n = 7) | 3.27 (1.82–518) |  |  |  |
Platelets (×109/L) (n = 6) | 325.5 (236.0–426.0) | Echocardiography (n = 6) |  |  |
 |  | Myocardial dysfunction |  | 4 (66.7) |
Biochemistry | Â | Pericarditis | Â | 1 (16.7) |
Procalcitonin (ng/mL) (n = 3) | 0.17 (0.10–69.52) | Valvulitis |  | 3 (50.0) |
CRP (mg/L) (n = 16) | 68.15 (19.88–143.0) | Coronary abnormalities |  | 2 (33.3) |
Haematocrit (%) ((n = 16) | 34.25 (31.6–36.1) |  |  |  |
Haemoglobin (g/L) (n = 18) | 11.5 (9.6–12.2) | Bacterial Blood Culture (n = 20) |  |  |
Creatinine (mmol/L) (n = 12) | 45.5 (34.0–52.0) | Positive |  | 1 (5.0) |
Sodium (mEq/L) (n = 12) | 134.0 (133.5–137.0) | Negative |  | 19 (95.5) |
Potassium (mEq/L) (n = 12) | 4.3 (3.91–4.97) |  |  |  |
Urea (mmol/L) (n = 12) | 3.8 (2.24–7.25) | COVID-19 testing |  |  |
 |  | PCR (n = 16) |  |  |
ALT (U/L) (n = 8) | 21.5 (8.5–35.65) | Positive |  | 4 (25.0) |
AST (U/L) (n = 8) | 34.5 (23.5–45.5) | Negative |  | 12 (75.0) |
Total Bilirubin (μmol/L) (n = 7) | 6.0 (5.0–11.0) |  |  |  |
Lactate (mmol/L) (n = 1) | 2.76 (2.76–2.76) | Rapid antigen test (n = 5) |  |  |
Albumin (g/dL) (n = 8) | 34.0 (25.5–41.5) | Positive |  | 0 (0.0) |
INR (n = 3) | 1.25 (0.85–1.3) | Negative |  | 5 (100.0) |
 |  | Antibody test (n = 1) |  | 1 (100.0) |
Positive | Â | 0 (0.0) | ||
Negative | Â | Â |